Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas
Nature Medicine2017Vol. 23(4), pp. 493–500
Citations Over TimeTop 1% of 2017 papers
Andrea Piunti, Rintaro Hashizume, Marc A. Morgan, Elizabeth T. Bartom, Craig Horbinski, Stacy A. Marshall, Emily J. Rendleman, Quanhong Ma, Yoh-hei Takahashi, Ashley R. Woodfin, Alexander V. Misharin, Nebiyu Abshiru, Rishi Lulla, Amanda Saratsis, Neil L. Kelleher, C. David James, Ali Shilatifard
Related Papers
- → Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function(2018)193 cited
- → Targeting EZH2 as cancer therapy(2021)54 cited
- → Targeting EZH2 for Cancer Therapy: Progress and Perspective(2015)64 cited
- → Inhibition of Polycomb Repressive Complex 2 activity reduces trimethylation of H3K27 and affects development in Arabidopsis seedlings(2019)20 cited
- → Automethylation of PRC2 promotes H3K27 methylation and is impaired in H3K27M pediatric glioma(2019)115 cited